Nitiloop Wins FDA 510(k) Clearance for Microcatheters
Nitiloop received FDA marketing clearance for its new Nova Cross Extreme and Nova Cross BTK.
The microcatheters combine low profile technology with enhanced guidewire and catheter support for safer and more effective lesion crossing.
The products are intended to be used in conjunction with conventional guidewires to access discrete regions of the coronary and peripheral vasculature. Nitiloop produces cardiovascular and peripheral microcatheters for complex lesions.